Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ·Healthcare·Biotechnology
$545.72
-2.27%
Mkt Cap $131.16B
Analyst Ratings
Buy
9
Hold
1
Sell
1
Price Target (106 analysts)
$559.33
Range $350.00 – $665.00
Implied Upside
+2.5%
Consensus $559.33 vs current $545.72